Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrizia Marini

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Current Opinion in Molecular Therapeutics|January 25, 2007
Drug evaluation: lexatumumab, an intravenous human agonistic mAb targeting TRAIL receptor 2Patrizia Marini
Current Medicinal Chemistry. Anti-Cancer Agents|July 23, 2003
Death receptor ligands: new strategies for combined treatment with ionizing radiationPatrizia Marini, Claus Belka
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 11, 2003
[Death inducing ligands in combination with ionizing radiation: objective and current knowledge]Claus Belka, Angelika Betsch, Patrizia Marini, et al.
Radiation Oncology (London, England)|October 29, 2009
Combined treatment with lexatumumab and irradiation leads to strongly increased long term tumour control under normoxic and hypoxic conditionsPatrizia Marini, Dorothea Junginger, Stefan Stickl, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 16, 2003
Molecular requirements for the combined effects of TRAIL and ionising radiationPatrizia Marini, Verena Jendrossek, Elise Durand, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 19, 2009
Efficacy of a triple treatment with irradiation, agonistic TRAIL receptor antibodies and EGFR blockadeMaximilian Niyazi, Patrizia Marini, Peter T Daniel, et al.
Oncology Reports|May 9, 2009
Efficacy of triple therapies including ionising radiation, agonistic TRAIL antibodies and cisplatinMaximilian Niyazi, Patrizia Marini, Peter T Daniel, et al.
International Journal of Radiation Oncology, Biology, Physics|January 31, 2004
Influence of hypoxia on TRAIL-induced apoptosis in tumor cellsMartin Weinmann, Patrizia Marini, Verena Jendrossek, et al.
International Journal of Radiation Oncology, Biology, Physics|August 22, 2009
Combination of the pro-apoptotic TRAIL-receptor antibody mapatumumab with ionizing radiation strongly increases long-term tumor control under ambient and hypoxic conditionsPatrizia Marini, Wilfried Budach, Maximilian Niyazi, et al.
BMC Cancer|January 18, 2005
Irradiation specifically sensitises solid tumour cell lines to TRAIL mediated apoptosisPatrizia Marini, Angelika Schmid, Verena Jendrossek, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Current Opinion in Molecular Therapeutics|January 25, 2007
Drug evaluation: lexatumumab, an intravenous human agonistic mAb targeting TRAIL receptor 2Patrizia Marini
Current Medicinal Chemistry. Anti-Cancer Agents|July 23, 2003
Death receptor ligands: new strategies for combined treatment with ionizing radiationPatrizia Marini, Claus Belka
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 11, 2003
[Death inducing ligands in combination with ionizing radiation: objective and current knowledge]Claus Belka, Angelika Betsch, Patrizia Marini, et al.
Radiation Oncology (London, England)|October 29, 2009
Combined treatment with lexatumumab and irradiation leads to strongly increased long term tumour control under normoxic and hypoxic conditionsPatrizia Marini, Dorothea Junginger, Stefan Stickl, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 16, 2003
Molecular requirements for the combined effects of TRAIL and ionising radiationPatrizia Marini, Verena Jendrossek, Elise Durand, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 19, 2009
Efficacy of a triple treatment with irradiation, agonistic TRAIL receptor antibodies and EGFR blockadeMaximilian Niyazi, Patrizia Marini, Peter T Daniel, et al.
Oncology Reports|May 9, 2009
Efficacy of triple therapies including ionising radiation, agonistic TRAIL antibodies and cisplatinMaximilian Niyazi, Patrizia Marini, Peter T Daniel, et al.
International Journal of Radiation Oncology, Biology, Physics|January 31, 2004
Influence of hypoxia on TRAIL-induced apoptosis in tumor cellsMartin Weinmann, Patrizia Marini, Verena Jendrossek, et al.
International Journal of Radiation Oncology, Biology, Physics|August 22, 2009
Combination of the pro-apoptotic TRAIL-receptor antibody mapatumumab with ionizing radiation strongly increases long-term tumor control under ambient and hypoxic conditionsPatrizia Marini, Wilfried Budach, Maximilian Niyazi, et al.
BMC Cancer|January 18, 2005
Irradiation specifically sensitises solid tumour cell lines to TRAIL mediated apoptosisPatrizia Marini, Angelika Schmid, Verena Jendrossek, et al.
Pageof 2